Option Care Health, Inc. (OPCH) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
27.27$'dan işlem gören Option Care Health, Inc. (OPCH), $4.33B değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 43/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 5 Şub 2026Option Care Health, Inc. (OPCH) Sağlık ve Boru Hattı Genel Bakışı
Option Care Health delivers comprehensive infusion therapy services directly to patients' homes and alternate sites, offering a lower-cost, patient-centric alternative to traditional hospital settings, capitalizing on the growing demand for convenient and accessible healthcare with a P/E ratio of 26.69.
Yatırım Tezi
Option Care Health presents a notable research candidate due to its strong market position, diversified service offerings, and favorable industry trends. The company's focus on home and alternate site infusion services aligns with the growing demand for convenient and cost-effective healthcare solutions. With a gross margin of 19.4% and a profit margin of 3.8%, Option Care Health demonstrates its ability to generate sustainable profitability. Key value drivers include the increasing prevalence of chronic diseases, the shift towards value-based care, and the expansion of the company's service network. Upcoming catalysts include continued organic growth, strategic acquisitions, and the potential for new partnerships with healthcare providers and payers. Investors may want to evaluate Option Care Health for its long-term growth potential and its ability to deliver superior returns in the evolving healthcare landscape.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $5.55 billion, reflecting investor confidence in the company's growth prospects.
- P/E ratio of 26.69, indicating a reasonable valuation relative to earnings.
- Gross margin of 19.4%, demonstrating the company's ability to manage costs effectively.
- Profit margin of 3.8%, showcasing the company's profitability in a competitive market.
- Beta of 0.84, suggesting lower volatility compared to the overall market.
Rakipler & Benzerleri
Güçlü Yönler
- Comprehensive range of infusion therapies and services.
- Established network of infusion centers and healthcare professionals.
- Strong relationships with healthcare providers and payers.
- Focus on patient-centered care and quality outcomes.
Zayıflıklar
- Dependence on reimbursement rates from payers.
- Exposure to regulatory changes and healthcare reforms.
- Competition from other home infusion providers.
- Potential for adverse events and liability claims.
Katalizörler
- Ongoing: Continued organic growth driven by increasing demand for home infusion therapy.
- Ongoing: Strategic acquisitions to expand geographic reach and service capabilities.
- Upcoming: Potential for new partnerships with healthcare providers and payers.
- Ongoing: Technological innovation to improve operational efficiency and patient experience.
- Ongoing: Increased market penetration through expanded sales and marketing efforts.
Riskler
- Potential: Changes in reimbursement policies that could reduce revenue.
- Ongoing: Increased competition from other home infusion providers.
- Potential: Adverse regulatory actions that could impact operations.
- Potential: Economic downturn and reduced healthcare spending.
- Ongoing: Dependence on key personnel and the ability to attract and retain talent.
Büyüme Fırsatları
- Expansion of Service Offerings: Option Care Health can expand its service offerings to include additional therapies and services, such as specialty pharmacy services and remote patient monitoring. This would allow the company to cater to a broader range of patient needs and increase its revenue per patient. The market for specialty pharmacy services is estimated to be worth billions of dollars, providing a significant growth opportunity for Option Care Health. Timeline: Ongoing.
- Strategic Acquisitions: Option Care Health can pursue strategic acquisitions to expand its geographic reach and enhance its service capabilities. This would allow the company to enter new markets and gain access to new technologies and expertise. The market for home infusion services is fragmented, providing ample opportunities for consolidation. Timeline: Ongoing.
- Partnerships with Healthcare Providers and Payers: Option Care Health can forge partnerships with healthcare providers and payers to integrate its services into their care delivery models. This would allow the company to gain access to a larger patient population and improve its reimbursement rates. The shift towards value-based care is driving increased collaboration between healthcare providers and payers. Timeline: Ongoing.
- Technological Innovation: Option Care Health can invest in technological innovation to improve its operational efficiency and enhance the patient experience. This includes developing new software platforms, implementing remote patient monitoring systems, and leveraging data analytics to optimize care delivery. The market for healthcare technology is rapidly evolving, providing opportunities for Option Care Health to gain a competitive advantage. Timeline: Ongoing.
- Increased Market Penetration: Option Care Health can increase its market penetration by expanding its sales and marketing efforts and targeting new patient populations. This includes raising awareness of the benefits of home infusion therapy and educating healthcare providers about the company's services. The market for home infusion services is underpenetrated, providing ample opportunities for growth. Timeline: Ongoing.
Fırsatlar
- Expansion into new geographic markets.
- Development of new therapies and services.
- Strategic acquisitions and partnerships.
- Increased adoption of home infusion therapy.
Tehditler
- Changes in reimbursement policies.
- Increased competition from other providers.
- Adverse regulatory actions.
- Economic downturn and reduced healthcare spending.
Rekabet Avantajları
- Established network of infusion centers and healthcare professionals.
- Strong relationships with healthcare providers and payers.
- Comprehensive service offerings covering a wide range of therapies and conditions.
- Focus on providing high-quality, patient-centered care.
- Proprietary technology and data analytics capabilities.
OPCH Hakkında
Option Care Health, Inc. was founded to provide accessible and personalized infusion therapy services outside of traditional hospital settings. Recognizing the growing need for convenient and cost-effective healthcare solutions, the company has evolved into a leading provider of home and alternate site infusion services across the United States. Option Care Health offers a broad spectrum of therapies, including anti-infective treatments, home parenteral and enteral nutrition, immunoglobulin infusions, and treatments for chronic inflammatory and neurological disorders. These services cater to patients with a wide range of conditions, from cancer and heart failure to immune deficiencies and rare diseases. The company's commitment to patient care extends beyond therapy delivery, encompassing comprehensive nursing services and support to ensure optimal outcomes. Headquartered in Bannockburn, Illinois, Option Care Health operates a network of infusion centers and employs a team of skilled healthcare professionals dedicated to providing high-quality, patient-centered care. With a market capitalization of $5.55 billion, Option Care Health is strategically positioned to capitalize on the increasing demand for home-based healthcare solutions, offering a compelling value proposition for patients, providers, and payers alike. The company's focus on innovation and personalized care continues to drive its growth and solidify its position as a leader in the home infusion market.
Ne Yaparlar
- Provides anti-infective therapies at home.
- Offers home infusion services for heart failure patients.
- Delivers parenteral and enteral nutrition support for various conditions.
- Administers immunoglobulin infusion therapies for immune deficiencies.
- Treats chronic inflammatory disorders like Crohn's disease and arthritis.
- Manages neurological disorders such as ALS and muscular dystrophy with infusion therapies.
- Provides infusion therapies for bleeding disorders.
- Offers specialized therapies for high-risk pregnancies.
İş Modeli
- Provides infusion therapies and related services in patients' homes and alternate sites.
- Contracts with healthcare providers and payers for reimbursement.
- Generates revenue through the delivery of therapies, nursing services, and other related services.
- Focuses on providing high-quality, patient-centered care to drive customer loyalty and referrals.
Sektör Bağlamı
Option Care Health operates within the growing home infusion market, driven by the increasing prevalence of chronic diseases, the aging population, and the shift towards value-based care. The market is characterized by intense competition, with players ranging from large national providers to smaller regional operators. Option Care Health differentiates itself through its comprehensive service offerings, its focus on patient-centered care, and its established relationships with healthcare providers and payers. The company is well-positioned to capitalize on the increasing demand for home-based healthcare solutions, offering a compelling value proposition for patients, providers, and payers alike.
Kilit Müşteriler
- Patients with acute and chronic conditions requiring infusion therapy.
- Hospitals and healthcare systems seeking to provide home-based infusion services.
- Physicians and other healthcare providers referring patients for infusion therapy.
- Managed care organizations and insurance companies covering the cost of infusion therapy.
Finansallar
Grafik & Bilgi
Option Care Health, Inc. (OPCH) hisse senedi fiyatı: $27.27 (+0.00, +0.00%)
Son Haberler
-
Earnings Scheduled For February 24, 2026
benzinga · 24 Şub 2026
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
OPCH için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
OPCH için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, OPCH'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Rakipler & Benzerleri
OPCH Healthcare Hisse Senedi SSS
OPCH için değerlendirilmesi gereken temel faktörler nelerdir?
Option Care Health, Inc. (OPCH) şu anda yapay zeka skoru 43/100, düşük puanı gösteriyor. Temel güçlü yan: Comprehensive range of infusion therapies and services.. İzlenmesi gereken birincil risk: Potential: Changes in reimbursement policies that could reduce revenue.. Bu bir finansal tavsiye değildir.
OPCH MoonshotScore'u nedir?
OPCH şu anda MoonshotScore'da 43/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
OPCH verileri ne sıklıkla güncellenir?
OPCH fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler OPCH hakkında ne diyor?
OPCH için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
OPCH'a yatırım yapmanın riskleri nelerdir?
OPCH için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Changes in reimbursement policies that could reduce revenue.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
OPCH'ın P/E oranı nedir?
OPCH için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için OPCH'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
OPCH aşırı değerli mi, yoksa düşük değerli mi?
Option Care Health, Inc. (OPCH)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
OPCH'ın temettü verimi nedir?
Option Care Health, Inc. (OPCH) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Stock data pending update.